ABSTRACT
Pancreatic tumors are the eighth commonest cause of cancer related death in the Western world 1,2 . The incidence in Europe as well as the US is around 10-12 per 100 000 per year 1,2 . The majority of these tumors are pancreatic adenocarcinoma. Despite surgical treatment with or without radio-and chemotherapy, the overall 5-year survival is around 4% and has hardly improved during recent decades 2-4 . So the prevalence of these tumors is roughly the same as the incidence.
